[1] |
Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus of clinical application of fixed-dose combination formulations
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893.
|
[2] |
CHEN Feng-fang, MA Jun, HUANG Jin, YIN Hong-yun, SHA Wei, YANG Guang-hong, FENG Yong-hong.
Preliminary study on establishing the diagnostic model for smear negative tuberculosis and stage Ⅰ/Ⅱ sarcoidosis with hilar/mediastinal lymphadenopathy and positive T-SPOT.TB results
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 832-837.
|
[3] |
DUAN Li-ming, DING Chao, LIU Yu-gang, WEI Lin, GU Zhen-ning.
Application value of video-assisted thoracoscopic surgery in the treatment of chronic tuberculous empyema
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 850-853.
|
[4] |
Beijing Chest Hospital, Capital Medical University, Clinical Trial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Guideline for clinical application of cycloserine in the treatment of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 533-540.
|
[5] |
HUANG Guo-jun, GAO Yuan, TANG Xi-liang, GAO Xiao, BAI Li-qiong.
Efficacy and safety of thymopentin in adjuvant treatment of retreatment positive pulmonary tuberculosis: a Meta-analysis
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 570-577.
|
[6] |
Beijing Chest Hospital,Capital Medical University, Clinical Trial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis.
Guideline for clinical application of clofazimine in the treatment of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 409-417.
|
[7] |
ZHANG Pei-ze, ZHENG Jun-feng, CAO Wei-peng, WANG Yu-xiang, CHEN Tao, FU Liang, DENG Guo-fang.
Study of the serum concentration at two time points after taking rifampicin
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 493-497.
|
[8] |
XIAO He-ping,LIU Yi-dian.
Revelation of novel coronavirus pneumonia epidemic prevention and control mechanism to tuberculosis prevention and control
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 311-315.
|
[9] |
CHEN Zhen-hua,LIU Bin-bin,CHEN Zhong-nan,TAN Yun-hong.
Establishment and preliminary evaluation of a diagnostic model for the new patients with pathogen-negative pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 266-271.
|
[10] |
MA Gai-xia,TIAN Li-ming,WANG Yu,QIU Lei,XUE Ling-na,LU Zhen-hui,ZHANG Hui-yong,GUO Xiao-yan.
Systematic evaluation and meta-analysis of integrated traditional Chinese and western medicine in the treatment of MDR-PTB
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 95-100.
|
[11] |
GU Ji-xiu, LI Qing, MA ling, LI Yin-hua, WANG Dong-dong, SI Hong-yan.
Application of next-generation sequencing technology in the diagnosis of drug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1203-1208.
|
[12] |
LI Ting, FAN Yun-fan, FU Ying-mei.
Research progress of extracellular RNA of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1250-1253.
|
[13] |
WANG Ze-ming, SUN Lin, SHEN A-dong.
Current status and thinking of clinical practice guidelines of tuberculosis in children
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1025-1028.
|
[14] |
BAI Yun-song, ZHANG Xue-jun, CAO Jun, FENG Lei, QI Xin-yu, GUO Dong, YAO Zi-ming, LI Cheng-xin.
Analysis of clinical efficacy of stageⅠanterior-posterior approach surgery for lumbar tuberculosis in children
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1048-1052.
|
[15] |
MAO Yi, ZENG Yi-lan, WU Gui-hui, JIANG Zhi-hao, FAN Lin.
Correlation analysis between clinical characteristics and flow cytometry cells subsets in peripheral blood of patients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1080-1086.
|